MT2013-31:Allo BMT for Metabolic Disorders, Osteopetrosis and Males With Rett Syndrome
Conditions: Mucopolysaccharidosis Disorders; Glycoprotein Metabolic Disorders; Peroxisomal Disorders; Severe Osteopetrosis; Rett Syndrome; SphingolipidosesInterventions: Biological: rabbit anti-thymocyte globulin; Drug: Fludarabine monophosphate; Drug: Busulfan; Drug: Cyclosporine A; Drug: Methylprednisolone; Drug: Mycophenylate Mofetil; Drug: Granulocyte-Colony Stimulating Factor; Procedure: bone marrow or peripheral blood stem cell (PBSC) transplantSponsor: Masonic Cancer Center, University of MinnesotaNot yet recruiting - verified June 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Methylprednisolone | Research | Rett Syndrome | Stem Cell Therapy | Stem Cells | Transplants